eflornithine has been researched along with Polycystic Ovarian Syndrome in 9 studies
Eflornithine: An inhibitor of ORNITHINE DECARBOXYLASE, the rate limiting enzyme of the polyamine biosynthetic pathway.
eflornithine : A fluoroamino acid that is ornithine substituted by a difluoromethyl group at position 2.
Excerpt | Relevance | Reference |
---|---|---|
" Additionally, novel cosmetic techniques like electrolysis, laser and use of topically applied eflornithine to tackle the most distressing feature of facial hirsutism associated with PCOS, non-pharmacological therapy like acupuncture and the role of herbal medicine in PCOS management have also been discussed." | 5.22 | Polycystic ovarian syndrome-current pharmacotherapy and clinical implications. ( Ali, T; Amin, F; Ara, R; Bader, GN; Kareem, O; Malik, A; Mir, SA; Rashid, R, 2022) |
" Moreover, assessment of biochemical hyperandrogenism is necessary, particularly in patients with unclear or absent hirsutism, and will include assessing total and free testosterone (T), and possibly dehydroepiandrosterone sulfate (DHEAS) and androstenedione, although these latter contribute limitedly to the diagnosis." | 4.93 | Androgen excess: Investigations and management. ( Azziz, R; Gavrilova-Jordan, L; Lizneva, D; Walker, W, 2016) |
"Hirsutism is the excessive growth of terminal hair in a typical male pattern in a female." | 2.61 | Hirsutism in Women. ( Bain, J; Matheson, E, 2019) |
"Hirsutism is defined as excess hair growth in androgen-dependent areas of the body in women." | 2.46 | Hirsutism: Diagnosis and management. ( Brodell, LA; Mercurio, MG, 2010) |
"Hirsutism is defined as the excessive growth of terminal hair on the face and body of a female in a typical male pattern distribution." | 2.44 | Hirsutism. ( Mofid, A; Seyyed Alinaghi, SA; Yazdani, T; Zandieh, S, 2008) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (44.44) | 29.6817 |
2010's | 4 (44.44) | 24.3611 |
2020's | 1 (11.11) | 2.80 |
Authors | Studies |
---|---|
Rashid, R | 1 |
Mir, SA | 1 |
Kareem, O | 1 |
Ali, T | 1 |
Ara, R | 1 |
Malik, A | 1 |
Amin, F | 1 |
Bader, GN | 1 |
Matheson, E | 1 |
Bain, J | 1 |
Lizneva, D | 1 |
Gavrilova-Jordan, L | 1 |
Walker, W | 1 |
Azziz, R | 1 |
Mason, H | 1 |
Colao, A | 1 |
Blume-Peytavi, U | 1 |
Rice, S | 1 |
Qureshi, A | 1 |
Pellatt, L | 1 |
Orio, F | 1 |
Atkin, SL | 1 |
Brodell, LA | 1 |
Mercurio, MG | 2 |
Franks, S | 1 |
Dawber, RP | 1 |
Mofid, A | 1 |
Seyyed Alinaghi, SA | 1 |
Zandieh, S | 1 |
Yazdani, T | 1 |
8 reviews available for eflornithine and Polycystic Ovarian Syndrome
Article | Year |
---|---|
Polycystic ovarian syndrome-current pharmacotherapy and clinical implications.
Topics: Acupuncture; Anovulation; Eflornithine; Female; Herbal Medicine; Hirsutism; Humans; Hydroxymethylglu | 2022 |
Hirsutism in Women.
Topics: Adrenal Hyperplasia, Congenital; Androgen Antagonists; Antineoplastic Agents, Hormonal; Contraceptiv | 2019 |
Androgen excess: Investigations and management.
Topics: 5-alpha Reductase Inhibitors; Acne Vulgaris; Alopecia; Androgen Antagonists; Androstenedione; Contra | 2016 |
Polycystic ovary syndrome (PCOS) trilogy: a translational and clinical review.
Topics: Acne Vulgaris; Alopecia; Anovulation; Cardiovascular Diseases; Eflornithine; Female; Hirsutism; Huma | 2008 |
Hirsutism: Diagnosis and management.
Topics: 5-alpha Reductase Inhibitors; Adrenal Hyperplasia, Congenital; Causality; Contraceptives, Oral; Diag | 2010 |
Guidance for the management of hirsutism.
Topics: Administration, Topical; Cosmetic Techniques; Eflornithine; Enzyme Inhibitors; Female; Hair Removal; | 2005 |
Hirsutism.
Topics: Diagnosis, Differential; Eflornithine; Enzyme Inhibitors; Female; Hair Removal; Hirsutism; Humans; H | 2008 |
Hirsutism: diagnosis and management.
Topics: Adrenal Hyperplasia, Congenital; Androgens; Contraceptives, Oral; Eflornithine; Enzyme Inhibitors; F | 2001 |
1 other study available for eflornithine and Polycystic Ovarian Syndrome
Article | Year |
---|---|
The investigation and management of hirsutism.
Topics: Adrenal Glands; Androgen Antagonists; Androgens; Contraceptives, Oral, Hormonal; Eflornithine; Endoc | 2012 |